Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEHR TEST SYSTEMS Director's Dealing 2023

Jul 17, 2023

32300_dirs_2023-07-17_38c923b4-21e3-435c-add1-7f5f6b19192a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2023-07-14

Reporting Person: SLAYEN HOWARD T (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-07-14 Common Stock M 10000 $2.0300 Acquired 156004 Direct
2023-07-14 Common Stock M 10000 $1.7700 Acquired 166004 Direct
2023-07-14 Common Stock M 16160 $1.6400 Acquired 182164 Direct
2023-07-14 Common Stock M 14711 $1.8600 Acquired 196875 Direct
2023-07-14 Common Stock M 10000 $1.3400 Acquired 206875 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-07-14 Non-Qualified Stock Option (right to buy) $1.3400 M 10000 Disposed 2027-10-20 Common Stock (10000) Direct
2023-07-14 Non-Qualified Stock Option (right to buy) $1.6400 M 16160 Disposed 2027-04-21 Common Stock (16160) Direct
2023-07-14 Non-Qualified Stock Option (right to buy) $1.7700 M 10000 Disposed 2026-10-22 Common Stock (10000) Direct
2023-07-14 Non-Qualified Stock Option (right to buy) $1.8600 M 14711 Disposed 2027-07-14 Common Stock (14711) Direct
2023-07-14 Non-Qualified Stock Option (right to buy) $2.0300 M 10000 Disposed 2025-11-23 Common Stock (10000) Direct

Footnotes

F1: The amount reported includes shares subject to unvested restricted stock units.

F2: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.

F3: Total number of shares became exercisable on this date.